Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

How to Prepare Project Report on Pharmaceutical Processing Industry?

Drug manufacturing companies work under strict laws and regulations. Their processes need to comply with relevant drugs act in their respective countries.

Therefore, if you are planning to invest in pharmaceutical processing, a good project report will be necessary. Besides the prominent aspects of a project report, you should pay close attention to the following issues in a pharmaceutical processing report.

1. Marketing

This industry is very competitive. I need not stress the value of detailed market analysis. You need to understand the status of market competition and the demand for pharmaceutical products. A proper market analysis will additionally help you prepare an excellent pharmaceutical business plan. Given your market analysis report, you will develop a marketing plan.

2. Government approval

In almost all countries, there are laws and regulations for the manufacture, distribution, and administration of drugs. Consider giving a status report on these requirements when making the final project status report.

3. Manufacturing Process

It would help if you had a picture of the process you will employ in making your drugs. Outline the quality checks and balances in the process. State the required pharmaceutical intermediates and their corresponding active pharmaceutical ingredients.

4. Machines and Equipment

You need to identify the equipment you will need, such as homogenizers, spectrophotometer, tabulating machines, etc. to ensure the machines meet quality specifications. You may also need to put down a plan to train workers on their operations.

How Does the Drug Manufacturing Process Work?

If you are an aspiring drug manufacturer, you should know how the bulk drug manufacturing process works. This is a complicated process and requires professional skills in molecular biology, medical microbiology, and pharmacy.

The process involves four steps, namely:

  • Milling
  • Granulation
  • Coating
  • Tabulation

Milling is important because it makes the drug powder uniform. It ensures uniform distribution of the active pharmaceutical ingredients. Additionally, milling makes it easier to formulate the drug into a syrup or emulsion.

After milling, you can use wet or dry granulation to form granules. You then coat them and compress the drugs using a tabulating machine. Alternatively, you can fill the granules into capsules.

For any chemical industry business ideas, prioritize the security of your staff. Ensure workers have sufficient PPEs. Have plans to protect them from chemical poisoning. Install eyewashes and emergency showers in both production units and laboratories.

Pre-Feasibility Report on Bulk Drug Manufacturing Process

Before you set up a feasibility report or start making a business plan, you first need to do a pre-feasibility study. It is the conclusions of this study that will make you decide whether to proceed to the project feasibility report or not.

Implementing a pharmacy business plan is an expensive affair. Please do not put any investment into a business plan of this magnitude without looking at its feasibility study report.

Considering the variety of pharmaceutical products, a feasibility plan will help you decide on the most relevant product for your target market. The results of pre-feasibility and feasibility studies will inform your marketing strategy plan. At the pre-feasibility stage, you get to review the technical skills required for the bulk drug manufacturing process. You also assess the knowledge level and determine whether you have the knowledge and skills.

Lastly, this report looks at the financial demands of a chemical project report on bulk drug processing. From here, you will decide on the feasibility of the project.

How to Grow Pharmaceutical Intermediates Market?

The pharmaceutical industry relies on pharmaceutical intermediates. We use these chemicals to produce active pharmaceutical ingredients (API). 

To grow the pharmaceutical intermediates market, therefore, we should focus on the drug manufacturing industry. Here are some tips on how we can grow this industry.

1. Investment in Research and Development

We should encourage governments and established drug manufacturers to invest in research and development of new medicines. New drug development will increase the need for pharmaceutical intermediates. Consequently, this will cause the growth of the industry.

2. Boost Generic Drug Manufacturing

Feasibility study reports for project ideas in pharmaceuticals show a growing demand for generics. This demand is particularly high in developing countries. More investment in generic drugs will result in increased demand for pharmaceutical intermediates.

3. Collaborations

It is quite expensive to run a pharmaceutical intermediate processing company. If you look at a project summary example for the local industry and you will notice the huge investment. One way of cushioning the industry is to encourage collaborations, mergers, and acquisitions. Working together gives small-scale companies a competitive advantage. It lowers their operation costs and improves revenue.

How to Set Up a Chemical Industry Business Plan?

Writing a chemical industry business plan begins with a pre-feasibility study. Here, you look at the various business ideas in chemical manufacturing. You then evaluate each of these ideas based on:

1. Skills and Knowledge

If you are interested in the chemical manufacturing industry, I assume that you have some skills or knowledge in this sector. If so, look at the skills required for each idea you have. Which of these ideas marches your skills and knowledge?

2. Financial Resources

Different chemical processes have different cost implications. Try to review each idea against the expected financial input. You can examine some business plan examples on the internet to get a hint on required inputs. Once you have a convincing pre-feasibility report, you can proceed to make a feasibility report meaning the idea is profitable and viable.

The next step in setting up a chemical industry business plan is to prepare a small business marketing plan. The results of your feasibility report will help do this.

Chemical manufacturing is not only expensive, but it is also strictly regulated by law. It would be best if you had an innovative marketing strategy to break even. It would be best if you did an accurate market analysis.

A project report on the pharmaceutical industry helps you assess the dynamics of the industry. You will want to know who the major chemical manufacturers are. You will also assess the availability of raw materials and machinery for your pharmaceutical industry.

In your project report, you will also address the technical aspects of the pharmaceutical manufacturing process. You need to draw a flow diagram for the process. Lastly, sit down and draw a business plan for your chemical industry business. You will need the information from all the above processes. Additionally, a business plan will consider the financial implications of your pharmaceutical industry project report.


We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 14 of 21 | Total 203 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Pharmaceutical Unit (Tablet, Capsules & Syrup) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Globally, the Indian pharmaceutical industry is ranked third largest in volume terms and 10th largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • A Tosh & Sons (India) Ltd. • Aarti Industries Ltd. • Agio Pharmaceuticals Ltd. • Alintosch Pharmaceuticals Ltd. • Anil Bioplus Ltd. • Anil Starch Products Ltd. • Astrix Laboratories Ltd. • B A & Brothers (Eastern) Ltd. • Caldern Pharmaceuticals Ltd. • Expicor Pharma Pvt. Ltd. • Fem Care Pharma Ltd. • German Remedies Ltd. • Hiran Orgochem Ltd. • Kedia Chemicals Inds. Ltd. • Kunshan Rotam Reddy Pharmaceutical Co. Ltd. • Larite Industries Ltd. • Lyka Labs Ltd. • Max Healthcare Institute Ltd. • Midas Pharmasec Ltd. • N G L Fine-Chem Ltd. • Norris Medicines Ltd. • Sanofi India Ltd. • Sayaji Industries Ltd. • Stellar Exports Ltd. • Suyash Laboratories Ltd. • United Breweries (Holdings) Ltd. • Vellanova Pharmaceuticals Ltd. • Vera Pharma Ltd. • Vivo Bio Tech Ltd. • Winmac Laboratories Ltd. • Yogi Pharmacy Ltd.
Plant capacity: Tablets: 500,000 Nos./Day,Capsules:500,000 Nos./Day,Syrup (100 ml Size):12,500 Nos./DayPlant & machinery: Rs 178 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 6342 Lakhs
Return: 31.00%Break even: 32.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablet And Capsules) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Globally, the Indian pharmaceutical industry is ranked third largest in volume terms and 10th largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • A Tosh & Sons (India) Ltd. • Aarti Industries Ltd. • Agio Pharmaceuticals Ltd. • Alintosch Pharmaceuticals Ltd. • Anil Bioplus Ltd. • Anil Starch Products Ltd. • Astrix Laboratories Ltd. • B A & Brothers (Eastern) Ltd. • Caldern Pharmaceuticals Ltd. • Expicor Pharma Pvt. Ltd. • Fem Care Pharma Ltd. • German Remedies Ltd. • Hiran Orgochem Ltd. • Kedia Chemicals Inds. Ltd. • Kunshan Rotam Reddy Pharmaceutical Co. Ltd. • Larite Industries Ltd. • Lyka Labs Ltd. • Max Healthcare Institute Ltd. • Midas Pharmasec Ltd. • N G L Fine-Chem Ltd. • Norris Medicines Ltd. • Sanofi India Ltd. • Sayaji Industries Ltd. • Stellar Exports Ltd. • Suyash Laboratories Ltd. • United Breweries (Holdings) Ltd. • Vellanova Pharmaceuticals Ltd. • Vera Pharma Ltd. • Vivo Bio Tech Ltd. • Winmac Laboratories Ltd. • Yogi Pharmacy Ltd.p
Plant capacity: Tablets:100,000 Strips./Day •Capsules:100,000 Strips./DayPlant & machinery: Rs 271 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 1866 Lakhs
Return: 32.00%Break even: 38.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablet And Capsules) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Globally, the Indian pharmaceutical industry is ranked third largest in volume terms and 10th largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. Thus, due to demand it is a good project for entrepreneurs to invest.
Plant capacity: Tablets:10,000 Strips/Day •Capsules:10,000 Strips/DayPlant & machinery: Rs 262 Lakhs
Working capital: -T.C.I: Cost of Project:Rs 554 Lakhs
Return: 28.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

IV Fluid and Dialysis Solution - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Intravenous therapy IV therapy is the infusion of liquid substances directly into a vein. Intravenous simply means "within vein". Therapies administered intravenously are often called specialty pharmaceuticals. Compared with other routes of administration, the intravenous route is the fastest way to deliver fluids and medications throughout the body. The bioavailability of the medication is 100% in IV therapy. The majority of an IV solution is sterile water. Chemically, water is referred to as a “solvent.” A solvent is a substance that dissolves other materials called “solutes.” Within IV solutions, the solutes can be molecules called electrolytes (charged particles such as sodium, potassium, and chloride) and/or other larger compounds such as proteins or molecules. Patient needs IV fluid therapy for maintenance (to supply daily needs), replacement (to replace deficit and on-going losses) and resuscitation (to correct an intravascular or extracellular deficit). Therefore, it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • Ahlcon Parenterals (India) Ltd. • Amanta Healthcare Ltd. • Goa Formulations Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd. • Punjab Formulations Ltd. • Senbo Industries Ltd. •Shree Krishna Keshav Laboratories Ltd. •Span Medicals Ltd. •Wockhardt Health Care Ltd.
Plant capacity: IV Fluid NS5 (500 ml Size):8,000 Bottles/Day •IV Fluid DNS (500 ml Size): 8,000 Bottles/Day •IV Fluid RL (500 ml Size): 8,000 Bottles/Day •IV Fluid D5 (500 ml Size): 8,000 Bottles/Day •IV Fluid D10 (500 ml Size): 4,000 Bottles/Day •Dialysis Solution (1000Plant & machinery: Rs 315 Lakhs
Working capital: -T.C.I: Cost of Project :Rs 1151 Lakhs
Return: 28.41%Break even: 43.11%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablets, Syrup, Capsules & Ointment) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Plant Layout

The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices. They are subject to a variety of laws and regulations regarding the patenting, testing and ensuring safety and efficacy and marketing of drugs. The pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. The three major segments - domestic formulations, formulation exports and bulk drug exports - have traditionally been the backbone of the pharmaceutical industry. Tablets are solid unit dosage form of medicaments with or without suitable diluents and prepared either by molding or compression. They are solid, flat or biconvex disc in shape. They vary greatly in shape, size and weight which depend upon amount of medicament used and mode of administration. They also vary in hardness, thickness, and disintegration and dissolution characteristics and in other aspects depending upon their intended use and method of manufacture. Tablets are the most widely used solid dosage form of medicament. Because of their advantages their popularity is continuously increasing day by day. Thus, due to demand it is a good project for entrepreneurs to invest. Capacity • Metronidazole Compressed Tablets: 75,000 Nos/Day • Paracetamol Compressed Tablets: 75,000 Nos/Day • Erythromycin Compressed Tablets: 75,000 Nos/Day • Sulfamethoxazole and Trimethoprim Compressed Tablets: 75,000 Nos/Day • Metformin Film Coated Tablets: 83,333 Nos/Day • Amlodipine Besylate Sugar Coated Tablets: 33,333Nos/Day • Piroxicam Capsules: 3,00,000 Nos/Day • Loperamide Hydrochloride Capsules: 3,00,000 Nos/Day • Metronidazole Suspension : 66,666 Nos/Day • Paracetamol Suspension : 66,666 Nos/Day • Sulfamethoxazole and Trimethoprim Suspension : 66,666 Nos/Day • Tolu Balsm Cough Syrup : 66,666 Nos/Day • Vitamin a and Vitamin D3 Syrup: 66,666 Nos/Day • Ointment: 20,000 Nos/Day
Plant capacity: -Plant & machinery: Rs 840 Lakhs
Working capital: -T.C.I: Cost of Project :Rs 136219 Lakhs
Return: 36.84%Break even: 29.39%
Add to Inquiry Add to Inquiry Basket

Petroleum Jelly - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Layout

Petroleum jelly or petrolatum was discovered as a paraffin-like material coating oil rigs. Since then, it has been used in various ointments and as a lubricant. Petroleum jelly is mixture of mineral waxes and oils that together lock moisture in skin, moisturizing it to repair and relieve dryness. They are stabilized in such fashion that the oil appears to form the internal phase, whereas the wax compound forms the external phase. Petroleum jelly is made by the waxy petroleum material that formed on oil rigs and distilling it. The lighter and thinner oil-based products make up petroleum jelly, also known as white petrolatum or simply as petrolatum. Robert Chesebrough is the chemist who devised and patented this process. Basically, the crude material undergoes vacuum distillation. The still residue is then filtered through bone char to yield petroleum jelly. At room temperature, petroleum jelly is an odourless semi-solid which consists of a mixture of hydrocarbons. Petroleum jelly has fibrous or grease like structure and also possess discreet drop point and penetration value . Petroleum jelly may be considered as microcrystalline wax which has absorbed the oil, resulting in an amorphous jelly like mass. It is mostly available in two colours namely white and yellow. Petroleum jelly is hugely versatile, and it’s used all over the world to protect and heal dry skin, from dry, cracked hands to hard skin on heels, as well as for beauty purposes, like softening the lips or highlighting the cheekbones. Application sector Petroleum jelly is an ingredient in many cosmetics and lotions. Originally it was marketed as a burn ointment. Petroleum jelly also may be applied to dry or chapped skin to seal in moisture. A variation known as red veterinary petroleum confers some protection against UV (ultraviolet) exposure and has been used as a sunscreen. • Pharmaceuticals/ Cosmetics industry • Jelly filled cable • Leather industry • Rubber industry • Other miscellaneous application including rust prevention etc. Petroleum jelly white / yellow IP uses are as follows: • Skin ointment / Skin cream • Hair Vaseline • Pain balm • Cold cream and cosmetic preparations • Ophthalmic ointment • Vaporub Ointment Indian demand: Various Cosmetics and pharmaceuticals are used by the large number of people in general for wounds, cuts, burns, skin diseases. In today’s business word, more and cosmetics industries are coming up and thereby increasing the demand for the raw materials like petroleum jelly. Hence it can be assumed that the petroleum jelly is having very good market potential in view of development of cosmetic & pharmaceutical industry in India. Present demand for petroleum jelly including export demand is around 70000 metric tonne per annum Growth rate in demand for 2021: 7% per annum Indian producers include the following: • Eastern Petroleum (P) Ltd., Maharashtra • Mahatha Petroleum (P) Ltd., Tamilnadu • Panama Petrochem Gujarat • Gandhar Oil Refinery Maharashtra • Asian Oil Company Maharashtra • Bhakti Petrochem P Ltd., Maharashtra • Unicorn Petroleum Inds P Ltd., Maharashtra • Kim Chemicals Ltd , Maharashtra Global petroleum jelly market Global supplies of microcrystalline wax and petroleum jelly continue to shrink due to the reduction in API Group I and specifically base oil Group I production capacity. On the other hand, demand for microcrystalline wax and petroleum jelly continues to be strong, helped by the recovery in many parts of the world. The resultant rise in prices has motivated wax de oilers, blenders, specialty wax producers to seek alternatives. The interplay of supply and demand drivers and the penetration of alternate materials will set the future direction of this product market. While natural and organic products account for a small percentage of the total skin care market, their share is growing faster than the general market.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Paracetamol- Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Paracetamol, also known as acetaminophen or APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain. It is often sold in combination with other ingredients such as in many cold medications. In combination with opioid pain medication, paracetamol is used for more severe pain such as cancer pain and after surgery. It is typically used either by mouth or rectally but is also available intravenously. Effects last between two and four hours. Paracetamol lacks anti-inflammatory action in rheumatic disorders. However, it is less toxic than the Aspirin and does not produce anemia and liver damage, which sometimes result from the continued use of acetanilide andacetophenetidin. It is also an important intermediate in the manufacture of other pharmaceuticals like theantimalarial amodiaquine. The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. Global pharma companies are increasingly exploring low cost option to outsource research and manufacturing, because of emerging slow-down in patented drug sales and high cost of R&D.Thus, as an entrepreneur this project offers an exciting opportunity to you. Few Indian Major Players are as under • Ranbaxy (Daichi) • Dr. Reddy's Labs • Cipla • Lupin • AurobindoPharma • Sun Pharma • GlaxoSmithkline • CadilaPharma • Nicholas Piramal • WokhardtLifesciences
Plant capacity: 300,000 Kgs/annumPlant & machinery: 98 lakhs
Working capital: -T.C.I: Cost of Project: 495 lakhs
Return: 25.00%Break even: 40.00%
Add to Inquiry Add to Inquiry Basket

Paracetamol

Paracetamol, also known as acetaminophen or APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain. It is often sold in combination with other ingredients such as in many cold medications. In combination with opioid pain medication, paracetamol is used for more severe pain such as cancer pain and after surgery. It is typically used either by mouth or rectally but is also available intravenously. Effects last between two and four hours. Paracetamol lacks anti-inflammatory action in rheumatic disorders. However, it is less toxic than the Aspirin and does not produce anemia and liver damage, which sometimes result from the continued use of acetanilide and acetophenotidine. It is also an important intermediate in the manufacture of other pharmaceuticals like theantimalarialamodiaquine. The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. Global pharma companies are increasingly exploring low cost option to outsource research and manufacturing, because of emerging slow-down in patented drug sales and high cost of R&D.Any entrepreneur venture into this field will be successful. Few Indian Major Players are as under • Alta Laboratories Ltd. • Granules India Ltd. • HaffkineAjintha Pharmaceuticals Ltd. • Nalin Chemicals Ltd. • Neelachal Technologies Ltd • Pan Drugs Ltd.
Plant capacity: Paracetamol Tablets: 1500mt/annum Paracetamol Powder: 420mt/annumPlant & machinery: Rs 349 lakhs
Working capital: -T.C.I: Cost of Project: Rs 863 lakhs
Return: 27.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Sterile Water for Injection with BFS Technology

The objective of formulating and compounding sterile preparations is to provide adosage form of a labeled drug, in the stated potency that is safe to use if administeredproperly.Water for InjectionWater for injection is purified by distillation or reverse osmosis and is free of pyrogens (bacterial substance that can produce fever).Sterile water for injection USP is sterilized and packaged in single-dose containers not exceeding 1000 ml.Bacteriostatic water for injection is sterilized and contains one or more bacteriostatic agents in a container no larger than 30 ml. India’s pharmaceutical sector has seen unwavering growth in the past few years, going up to 23 billion USD in 2012 from 23 billion USD in 2002. Various industry reports suggest that the pharmaceutical sector in India has been growing consistently at the rate of 13-14% every year since the last five years.India has an organized pharmaceutical market of its own, which is being considered as a potential partner by other countries. The Indian Pharma Market is ranked number 3 in terms of volume and 10thin terms of market value.As a whole it is a good project for new entrepreneurs to invest. Few Indian Major Players are as under • Abaris Healthcare Pvt. Ltd. • AhlconParenterals (India) Ltd. • Core Laboratories Ltd. • Infutec Healthcare Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd. • Punjab Formulations Ltd. • Shree Krishna Keshav Laboratories Ltd.
Plant capacity: Ampoules 5 ml Size: 300,000 Th. Nos./annum Ampoules 10 ml Size: 260,000 Th. Nos./annum Ampoules 20 ml Size: 120,000 Th. Nos./annumPlant & machinery: Rs 607 lakhs
Working capital: -T.C.I: Cost of Project: Rs 917 lakhs
Return: 28.00%Break even: 55.00%
Add to Inquiry Add to Inquiry Basket

Soft Gelatin Capsules

Soft gelatin (also called softgel or soft elastic) capsules consist of one piece hermetically-sealed soft shells. Soft gelatin capsules are prepared by adding a plasticizer, such as glycerin or polyhydric alcohol (e.g., sorbitol), to gelatin. The plasticizer makes gelatin elastic. Soft gelatin capsules come in various shapes such as spherical, elliptical, oblong, and special tube shapes with and without twist off. They can contain non-aqueous liquids, suspensions, pasty materials, or dry powders. The term soft gelatin capsules is commonly abbreviated to 'softgels'.Soft gelatin capsules has an advantages over hard gelatin capsules is to make a liquid formulation containing the drug in a one-piece outer gelatin shell. The demand of the soft gel capsules is increasing due to the available customization facilities for the molds and content as per customer needs. The soft gel capsules have many application areas out of which pharmaceutical, cosmetics and health supplements contribute the major shares to the growth of the global soft gel capsules market.The Global Softgel Capsules Market is poised to grow at a CAGR of around 5.4% over the next decade to reach approximately $316.6 billion by 2025.Thus, as an entrepreneur this project offers an exciting opportunity to you. Few Indian Major Players are as under • C J Gelatine Products Ltd • Fortcaps Healthcare Ltd. • Healthcaps India Ltd. • India Gelatine& Chemicals Ltd. • K P Gelatines& Chemicals India Ltd. • Narmada Gelatines Ltd. • Rama Industries Ltd. • Sterling Biotech Ltd.
Plant capacity: 1,800,000 Th.Nos./annumPlant & machinery: Rs 261 lakhs
Working capital: -T.C.I: Cost of Project: Rs 478lakhs
Return: 27.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 14 of 21 | Total 203 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top